Skip to main
CERT
CERT logo

Certara (CERT) Stock Forecast & Price Target

Certara (CERT) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 23%
Buy 46%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Certara Inc's revenue composition indicates a robust growth trajectory, with services accounting for 66% of its revenue, although the overall services growth rate faced a slowdown in 2022 due to regulatory pressures. However, the acquisition of Pinnacle 21 has positively impacted the company's software revenue, contributing approximately 10% of total revenue and 25% of software revenue in FY23, and this segment is expected to grow above the corporate average. The ongoing secular growth in the biosimulation market is anticipated to drive demand for Certara's innovative solutions, which deliver significant time and cost savings in drug discovery and development processes.

Bears say

Certara Inc faces significant challenges that could negatively impact its financial outlook. A potential shift back toward services could hinder gross margin expansion, as service contributions are expected to drag on overall profitability despite an assumed gross margin of 60%+. Additionally, while the regulatory environment has historically been favorable, ongoing requirements for regulatory acceptance of new use cases may limit future growth opportunities for the company's biosimulation technologies.

Certara (CERT) has been analyzed by 13 analysts, with a consensus rating of Buy. 23% of analysts recommend a Strong Buy, 46% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Certara and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Certara (CERT) Forecast

Analysts have given Certara (CERT) a Buy based on their latest research and market trends.

According to 13 analysts, Certara (CERT) has a Buy consensus rating as of Jun 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Certara (CERT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.